SGAM
IRWD icon

Smith Group Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Smith Group Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-230
Closed -$3K – 327
2021
Q4 		$3K Hold
230
– – ﹤0.01% 354
2021
Q3 		$3K Hold
230
– – ﹤0.01% 363
2021
Q2 		$3K Hold
230
– – ﹤0.01% 354
2021
Q1 		$3K Sell
230
-6,600
-97% -$69.7K ﹤0.01% 318
2020
Q4 		$78K Hold
6,830
– – ﹤0.01% 210
2020
Q3 		$61K Buy
6,830
+2,690
+65% +$26.7K ﹤0.01% 212
2020
Q2 		$43K Sell
4,140
-30
-0.7% -$307 ﹤0.01% 207
2020
Q1 		$42K Hold
4,170
– – ﹤0.01% 249
2019
Q4 		$56K Hold
4,170
– – ﹤0.01% 273
2019
Q3 		$36K Hold
4,170
– – ﹤0.01% 297
2019
Q2 		$46K Sell
4,170
-809
-16% -$9.06K ﹤0.01% 277
2019
Q1 		$56K Sell
4,979
-14,447
-74% -$161K ﹤0.01% 295
2018
Q4 		$169K Sell
19,426
-359
-2% -$4.12K 0.01% 254
2018
Q3 		$306K Buy
19,785
+1,433
+8% +$22.7K 0.01% 222
2018
Q2 		$294K Sell
18,352
-12
-0.1% -$178 0.01% 222
2018
Q1 		$237K Sell
18,364
-14,328
-44% -$179K 0.01% 235
2017
Q4 		$410K Hold
32,692
– – 0.01% 218
2017
Q3 		$432K Hold
32,692
– – 0.01% 225
2017
Q2 		$517K Sell
32,692
-1,433
-4% -$20.8K 0.02% 212
2017
Q1 		$488K Sell
34,125
-23
-0.1% -$314 0.01% 186
2016
Q4 		$437K Hold
34,148
– – 0.01% 198
2016
Q3 		$454K Hold
34,148
– – 0.01% 187
2016
Q2 		$374K Sell
34,148
-597
-2% -$5.83K 0.01% 201
2016
Q1 		$318K Buy
+34,745
New +$287K 0.01% 177
2015
Q3 		– Sell
-88,994
Closed -$899K – 422
2015
Q2 		$899K Sell
88,994
-8,823
-9% -$103K 0.03% 174
2015
Q1 		$1.31M Buy
+97,817
New +$1.28M 0.04% 162

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Smith Group Asset Management's IRWD Position: Q1 2022 in Review

Smith Group Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2022, closing a stake of 230 shares — an estimated $3K sold.

Smith Group Asset Management first reported a position in IRWD in Q1 2015 and held it in 26 quarters. The position peaked at $1.31M in Q1 2015. 221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

  • Smith Group Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Smith Group Asset Management sold 230 Ironwood Pharmaceuticals shares in Q1 2022, an estimated $3K.
  • Smith Group Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2015 and held it in 26 quarters.
  • Smith Group Asset Management's Ironwood Pharmaceuticals position peaked at $1.31M in Q1 2015.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.